LOXL4
Lysyl oxidase homolog 4
Also known as: FLJ21889, LOXC, LOXL4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JB6
- Gene
- LOXL4
- Ensembl
- ENSG00000138131
- Chromosome
- 10
- Canonical length
- 756 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a member of the lysyl oxidase gene family. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyses the first step in the formation of crosslinks in collagens and elastin. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
756 residues, UniProt reviewed canonical sequence.
>Q96JB6|LOXL4
1 MAWSPPATLF LFLLLLGQPP PSRPQSLGTT KLRLVGPESK PEEGRLEVLH QGQWGTVCDD
61 NFAIQEATVA CRQLGFEAAL TWAHSAKYGQ GEGPIWLDNV RCVGTESSLD QCGSNGWGVS
121 DCSHSEDVGV ICHPRRHRGY LSETVSNALG PQGRRLEEVR LKPILASAKQ HSPVTEGAVE
181 VKYEGHWRQV CDQGWTMNNS RVVCGMLGFP SEVPVDSHYY RKVWDLKMRD PKSRLKSLTN
241 KNSFWIHQVT CLGTEPHMAN CQVQVAPARG KLRPACPGGM HAVVSCVAGP HFRPPKTKPQ
301 RKGSWAEEPR VRLRSGAQVG EGRVEVLMNR QWGTVCDHRW NLISASVVCR QLGFGSAREA
361 LFGARLGQGL GPIHLSEVRC RGYERTLSDC PALEGSQNGC QHENDAAVRC NVPNMGFQNQ
421 VRLAGGRIPE EGLLEVQVEV NGVPRWGSVC SENWGLTEAM VACRQLGLGF AIHAYKETWF
481 WSGTPRAQEV VMSGVRCSGT ELALQQCQRH GPVHCSHGGG RFLAGVSCMD SAPDLVMNAQ
541 LVQETAYLED RPLSQLYCAH EENCLSKSAD HMDWPYGYRR LLRFSTQIYN LGRTDFRPKT
601 GRDSWVWHQC HRHYHSIEVF THYDLLTLNG SKVAEGHKAS FCLEDTNCPT GLQRRYACAN
661 FGEQGVTVGC WDTYRHDIDC QWVDITDVGP GNYIFQVIVN PHYEVAESDF SNNMLQCRCK
721 YDGHRVWLHN CHTGNSYPAN AELSLEQEQR LRNNLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against LOXL4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 19 nTPM
- blood vessel: 13 nTPM
- cervix: 13 nTPM
- breast: 11 nTPM
- colon: 10 nTPM
- seminal vesicle: 10 nTPM
Single-cell type
- pancreatic islet cells: 68 nCPM
- salivary basal cells: 61 nCPM
- thymic myoid cells: 60 nCPM
- hepatic stellate cells: 32 nCPM
- renal collecting duct principal cells: 30 nCPM
- respiratory basal cells: 29 nCPM
Immune cell
- NK-cell: 0.5 nTPM
- plasmacytoid DC: 0.2 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 5.5 nTPM
- medulla oblongata: 3.6 nTPM
- midbrain: 3.6 nTPM
- hypothalamus: 3.3 nTPM
- pons: 3.2 nTPM
- cerebellum: 3.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.16
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LOXL4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LOXL4 as an antibody target. Whether an autoantibody or antibody against LOXL4 could matter depends on whether native LOXL4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LOXL4 is annotated as secreted, so native LOXL4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LOXL4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...